Skip to main content
. 2013 Dec 5;5(3):297–304. doi: 10.1111/jdi.12178

Table 6. Odds ratios of colorectal adenoma according to quartiles of fasting serum insulin stratified by body mass index.

OR (95% CI) P for trend
BMI < 25 kg/m2 Q1 Q2 Q3 Q4
Insulin, μIU/mL (median) <3.2 (2.25) 3.2 – 4.6 (3.92) 4.6 – 6.5 (5.49) >6.5 (9.19)
Adenoma cases/non‐cases 513/1,103 503/1,054 514/1,053 545/950
Univariate 1.0 (ref) 1.03 (0.88 –1.19) 1.05 (0.91 –1.22) 1.23 (1.06 –1.43)a <0.05
Model 1 1.0 (ref) 1.08 (0.92 –1.28) 1.11 (0.94 –1.31) 1.26 (1.07 –1.49)a <0.05
BMI ≥ 25 kg/m2 Q1 Q2 Q3 Q4 P for trend
Insulin, μIU/mL (median) <4.9 (3.74) 4.9 – 6.8 (5.89) 6.8 – 9.7 (8.15) >9.7 (13.89)
Adenoma cases/non‐cases 403/464 365/482 369/464 394/449
Univariate 1.0 (ref) 0.87 (0.72 –1.05) 0.92 (0.76 –1.12) 1.01 (0.84 –1.22) NS
Model 1 1.0 (ref) 0.95 (0.77 –1.17) 1.01 (0.82 –1.24) 1.13 (0.92 –1.39) NS
a

P < 0.05. Model 1: Adjusted for age, sex, current smoking, alcohol drinking, family history of colorectal cancer. CI, confidence interval; NS, not significant; OR, odds ratio; Q, quartile.